This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Eastman Kodak, Rambus: After-Hours Trading

Stocks in this article: EK RMBS BRCM MNTA BAX

NEW YORK ( TheStreet) -- Shares of Eastman Kodak (EK) leapt in late trades on Thursday after the company agreed to divest its Eastman Gelatine business and named Laura Quatela president.

Eastman Kodak is selling the business, which has roughly 95 employees and makes gelatin used in photographic movie film and paper emulsions, to Rousselot, which is part of the Vion Food Group. Financial terms weren't disclosed.

Kodak said Quatela, who most recently served as general counsel, will serve as president alongside current president Philip Faraci, and that both will report to CEO Antonio Perez.

The stock was last quoted at 77 cents, up 22%, on volume of more than 400,000, according to Nasdaq.com.

Momenta Pharmaceuticals

Shares of Momenta Pharmaceuticals (MNTA) surged in the extended session after the company inked a deal to collaborate with Baxter International (BAX) on the development of follow-on biologics.

The deal calls for Baxter to make an upfront cash payment of $33 million to Momenta covering the initial collaboration on up to six follow-on biologic compounds. Momenta could receive additional payments based upon the development of the compounds and milestones reached. The parties expect to close the deal in the first quarter.

Momenta shares were last quoted at $18.10, up 6.4%, on volume of nearly 50,000, according to Nasdaq.com. Based on Thursday's regular-session close at $17.02, the stock was up more than 9% in the past year.

Rambus

A patent licensing agreement with Broadcom (BRCM) sent shares of Rambus (RMBS) higher in the after-hours session.

The five-year deal covers the use of Rambus-patented technology in Broadcom chips, and resolves litigation between the two parties. Financial terms weren't disclosed.

Rambus shares leapt nearly 8% to $7.89 in late trades on volume of 65,000, while Broadcom's stock was unchanged at $29.77.

-- Written by Michael Baron in New York.



>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to: tips@thestreet.com

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,961.62 +156.82 0.88%
S&P 500 2,077.60 +6.95 0.34%
NASDAQ 4,778.9480 +13.5680 0.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs